2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-03-09
±³À°ÀÏÀÚ : 2024-03-09
±³À°Àå¼Ò : ´ë±¸ÀÎÅͺҰíÈ£ÅÚ(Áñ°Å¿î Ȧ,ÇູÇÑ È¦)
±³À°ÁÖÁ¦ : 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ
´ã´çÀÚ : ±èÁø¿Á
¿¬¶ôó : 010-2563-6902
À̸ÞÀÏ : ksbtp.svc@gmail.com
±³À°Á¾·ù : Á¤½Å°Ç°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 12 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü¹®ÀÇ 40,000¿ø (ÇöÀåµî·Ï 50,000¿ø)±ºÀü¹®ÀÇ, °øº¸ÀÇ, Àü°øÀÇ 20,000¿ø (ÇöÀåµî·Ï 30,000¿ø)Æò»ýȸ¿ø ¸éÁ¦ (ÇöÀåµî·Ï 10,000¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 09:40~10:05 Ketamine/esketamine and psychedelics for depression Á¤¼º¿ø(°è¸íÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 10:05~10:30 MDMA for PTSD À±¼®È£(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 10:30~10:55 Muscarinic drugs for psychosis ÀÌ¿µÁö(°æ»óÀÇ´ë)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 10:55~11:05 Q&A ( )
ÈÞ½Ä 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 11:05~11:15 CoffeeBreak ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 11:15~11:40 The digital clinic: Implementing technology and augmenting care for mental health ÀÌÁ¤Àç(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 11:40~12:05 A technology-assisted life of recovery from psychosis ±è¼º¿Ï(Àü³²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 12:05~12:30 Digital phenotype to guide clinical interventions for suicide treatment ±è°æ¿ø(ºÎ»êÀÇ´ë)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 12:30~12:40 Q&A ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 12:40~13:40 Optimal treatment strategy for older adult with MDD and comorbidities ±èº´¼ö(°æºÏÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 13:40~14:05 Ketamine vs Electroconvulsive therapy for major depressive episode ±è¼ºÁø(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 14:05~14:30 Is bipolar mixed depression associated with a good response to psychotropic augmentation? ¹®Àº¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 14:30~14:55 The controversial use of antidepressant medications in bipolar depression: clinical rationale and possible iatrogenic effects ¼ºÇü¸ð(¼øõÇâÀÇ´ë)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 14:55~15:05 Q&A ( )
ÈÞ½Ä 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 15:05~15:15 CoffeeBreak ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 15:15~15:40 Electrophysiological and neurocognitive differences: What do they tell us about adult ADHD? Á¤Ç϶õ(±¹¸³³ªÁÖº´¿ø)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 15:40~16:05 Exploring the reward system dysfunction in ADHD: A neuroimaging journey ÃÖÅ¿µ(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 16:05~16:30 Are there positive aspects of ADHD? Á¤¿î¼±(°æºÏÀÇ´ë)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ Áñ°Å¿î Ȧ 16:30~16:40 Q&A ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 09:40~10:05 ¸¶¾à·ù Áßµ¶ ȯÀÚÀÇ ¾à¹°Àû Ä¡·á Àå¿ÁÁø(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 10:05~10:30 ¸¶¾à·ù Áßµ¶ ȯÀÚÀÇ ºñ¾à¹°Àû Ä¡·á ¹Ú½ÂÇö(´ëµ¿º´¿ø)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 10:30~10:55 ¸¶¾à·ù ¹üÁË µ¿Ç⠱躸¼º(ºÎ»ê°ËÂûû)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 10:55~11:05 Q&A ( )
ÈÞ½Ä 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 11:05~11:15 CoffeeBreak ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 11:15~11:40 º¯ºñ¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ °Í(º´Å»ý¸®, Áø´Ü ¹× Ä¡·á) ±è°æ¿Á(¿µ³²ÀÇ´ë ¼Òȱ⳻°ú)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 11:40~12:05 Àú³ªÆ®·ýÇ÷Áõ ±èÀ±¹Ì(ÀÎÁ¦ÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 12:05~12:30 Á¤½Å°ú ¾à¹°Ä¡·á¿Í Å»¸ð ¹Ú¼ÒÈñ(ÀÎÁ¦ÀÇ´ë ÇǺΰú)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 12:30~12:40 Q&A ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 13:40~14:05 ºÒ¸é¿¡¼ÀÇ ºñħ½ÀÀû ³úÀÚ±ØÄ¡·á ±è¿¬¼ö(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 14:05~14:30 ¼Ò¾Æû¼Ò³â°ú °æµÎ°³ÀÚ±âÀڱؼú Á¤Áö¿î(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 14:30~14:55 Ä¡¸Å¿Í °æµÎ°³ÀÚ±âÀڱؼú ±èÇö¼ö(µ¿¾ÆÀÇ´ë)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 14:55~15:05 Q&A ( )
ÈÞ½Ä 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 15:05~15:15 CoffeeBreak ( )
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 15:15~15:55 ÀÇ·á¿Í ¼»ç ±×¸®°í µ¹º½- ¼»çÀÇÇÐÀÇ À̷аú ½ÇÁ¦ ȲÀÓ°æ(Á¦ÁÖÀÇ´ë ÀÇ·áÀι®ÇÐ)
±³À°½Ã°£ 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 15:55~16:35 ¹®ÇÐÄ¡·á¿Í ¼»ç Á¶Àº»ó(°Ç±¹´ëÇб³ ´ëÇпø ¹®Çп¹¼ú½É¸®Ä¡·áÇаú)
Åä·Ð 03¿ù 09ÀÏ ´ë±¸ÀÎÅͺҰíÈ£ÅÚ ÇູÇÑ È¦ 16:35~16:40 Q&A ( )